Literature DB >> 25611757

Management of labor analgesia in a patient with acute myeloid leukemia.

Kelly G Elterman1, Jonathan R Meserve, Martha Wadleigh, Michaela K Farber, Lawrence C Tsen.   

Abstract

The anesthetic implications of acute leukemia in pregnancy have not been reported. We describe the anesthetic management of a laboring primigravida at 34 weeks' gestation with new-onset acute myeloid leukemia. With multidisciplinary consultation, we recommend that neuraxial anesthesia be avoided in new-onset acute myeloid leukemia due to the risk of introducing malignant cells into the central nervous system, which can spread the disease and complicate management. We discuss the use of a fentanyl patient-controlled analgesia and dexmedetomidine as a method of labor analgesia, and the potential benefits of the latter medication in the obstetric population.

Entities:  

Year:  2014        PMID: 25611757     DOI: 10.1213/XAA.0000000000000076

Source DB:  PubMed          Journal:  A A Case Rep        ISSN: 2325-7237


  2 in total

1.  Dexmedetomidine for every Cesarean delivery…maybe not?

Authors:  Lesley Bautista; Ronald B George
Journal:  Can J Anaesth       Date:  2019-03-27       Impact factor: 5.063

2.  Intravenous Dexmedetomidine as an Adjunct to Neuraxial Anesthesia in Cesarean Delivery: A Retrospective Chart Review.

Authors:  Paul R Davis; Hans P Sviggum; Daniel J Delaney; Katherine W Arendt; Adam K Jacob; Emily E Sharpe
Journal:  Anesthesiol Res Pract       Date:  2021-12-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.